PRESS RELEASE published on 06/04/2024 at 19:30, 2 years 1 month ago Crossject announces highly successful closing of its €8 million rights offering Crossject successfully closes €8 million rights offering, securing funding for ZEPIZURE® development and FDA approval. Gemmes Venture remains a key supporter FDA Approval Rights Offering Crossject ZEPIZURE® Gemmes Venture
BRIEF published on 05/30/2024 at 10:35, 2 years 1 month ago Crossject: Publication of Clinical Data on ZEPIZURE® Crossject ZEPIZURE® Neurology And Therapy Midazolam Needle-free Injection
PRESS RELEASE published on 05/30/2024 at 10:30, 2 years 1 month ago Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy Crossject announces publication of clinical data on ZEPIZURE in Neurology and Therapy, highlighting bioequivalence versus Dormicum, early onset, and low variability Clinical Data Crossject Neurology And Therapy ZEPIZURE Needle-free Auto-injector
Published on 07/21/2026 at 17:05, 4 hours 34 minutes ago Caldwell Appoints Steven Price Co-Leader of Life Sciences & Healthcare Practice
Published on 07/21/2026 at 15:00, 6 hours 39 minutes ago Four Nines Gold Begins Maiden Drill Program at Hayden Hill
Published on 07/21/2026 at 15:00, 6 hours 39 minutes ago BlackBerry SecuSUITE Secures Renewed NIAP Common Criteria Certification, Reinforcing Leadership in Sovereign Government-Grade Secure Communications
Published on 07/21/2026 at 14:55, 6 hours 44 minutes ago Vulcan Minerals Inc. - Drilling Completed at Carbonear Zinc-Lead SEDEX Project in Newfoundland
Published on 07/21/2026 at 14:30, 7 hours 9 minutes ago Sarama Completes Sale of its West Australian Gold Assets
Published on 07/21/2026 at 18:50, 2 hours 48 minutes ago Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Published on 07/21/2026 at 18:15, 3 hours 23 minutes ago EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics
Published on 07/21/2026 at 17:50, 3 hours 48 minutes ago The New Measure of an EV Isn't Range, It's Peace of Mind
Published on 07/21/2026 at 17:40, 3 hours 58 minutes ago EQS-Adhoc: Airbus to present new mid-term outlook, strengthen commitment to profitable growth and shareholder returns during investor update
Published on 07/21/2026 at 17:37, 4 hours 1 minute ago EQS-Adhoc: Branicks Group AG updates the timetable for the publication of its 2025 annual and consolidated financial statements in light of ongoing restructuring negotiations
Published on 07/20/2026 at 18:20, 1 day 3 hours ago Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 1 day 3 hours ago Reporting on share buyback transactions carried out between July 8 and July 9, 2026
